Dr Francis Dehle has 15 years’ experience in market access and reimbursement submissions, with expertise in economic modelling, clinical evidence and patient insights across Australia and international markets. He has worked both as a consultant and within the market access team of a global pharmaceutical company.

Dr Francis joined HTANALYSTS in July 2011 and is currently a Principal specialising in market access and reimbursement submissions.

At HTANALYSTS, his work includes feasibility studies, strategy development, economic modelling and the management of PBAC, MSAC, PHARMAC and co-dependent reimbursement submissions for new medicines, LSDP listings, medical devices and diagnostic technologies. He has worked across most therapeutic areas.

After completing an undergraduate degree in biomedical science, he obtained a PhD in pharmacology. Before joining HTANALYSTS, he held postdoctoral research positions at the Royal Adelaide Hospital in Thoracic Medicine and at the School of Chemistry and Physics at the University of Adelaide.

He has led market access and reimbursement submissions across pharmaceuticals, medical devices and diagnostic technologies in Australia and internationally.